These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 27405876)
1. Interleukin 21 - its potential role in the therapy of B-cell lymphomas. Bhatt S; Sarosiek KA; Lossos IS Leuk Lymphoma; 2017 Jan; 58(1):17-29. PubMed ID: 27405876 [TBL] [Abstract][Full Text] [Related]
2. Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma. Bhatt S; Matthews J; Parvin S; Sarosiek KA; Zhao D; Jiang X; Isik E; Letai A; Lossos IS Blood; 2015 Sep; 126(13):1555-64. PubMed ID: 26194763 [TBL] [Abstract][Full Text] [Related]
3. Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity. Bhatt S; Parvin S; Zhang Y; Cho HM; Kunkalla K; Vega F; Timmerman JM; Shin SU; Rosenblatt JD; Lossos IS Blood; 2017 Apr; 129(16):2246-2256. PubMed ID: 28137826 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-21: biology and application to cancer therapy. Andorsky DJ; Timmerman JM Expert Opin Biol Ther; 2008 Sep; 8(9):1295-307. PubMed ID: 18694350 [TBL] [Abstract][Full Text] [Related]
5. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Sarosiek KA; Malumbres R; Nechushtan H; Gentles AJ; Avisar E; Lossos IS Blood; 2010 Jan; 115(3):570-80. PubMed ID: 19965678 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells. de Totero D; Capaia M; Fabbi M; Croce M; Meazza R; Cutrona G; Zupo S; Loiacono F; Truini M; Ferrarini M; Ferrini S Exp Hematol; 2010 May; 38(5):373-83. PubMed ID: 20193734 [TBL] [Abstract][Full Text] [Related]
7. High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma. Akamatsu N; Yamada Y; Hasegawa H; Makabe K; Asano R; Kumagai I; Murata K; Imaizumi Y; Tsukasaki K; Tsuruda K; Sugahara K; Atogami S; Yanagihara K; Kamihira S Cancer Lett; 2007 Oct; 256(2):196-206. PubMed ID: 17624663 [TBL] [Abstract][Full Text] [Related]
8. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity. Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 signaling: functions in cancer and autoimmunity. Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166 [TBL] [Abstract][Full Text] [Related]
10. The role of IL-21 in hematological malignancies. Ma J; Ma D; Ji C Cytokine; 2011 Nov; 56(2):133-9. PubMed ID: 21824785 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-21: an interleukin-2 dependent player in rejection processes. Baan CC; Balk AH; Dijke IE; Korevaar SS; Peeters AM; de Kuiper RP; Klepper M; Zondervan PE; Maat LA; Weimar W Transplantation; 2007 Jun; 83(11):1485-92. PubMed ID: 17565322 [TBL] [Abstract][Full Text] [Related]
12. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796 [TBL] [Abstract][Full Text] [Related]
13. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899 [TBL] [Abstract][Full Text] [Related]
14. IL-21: roles in immunopathology and cancer therapy. Søndergaard H; Skak K Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910 [TBL] [Abstract][Full Text] [Related]
15. IL-21: a pleiotropic cytokine with potential applications in oncology. Croce M; Rigo V; Ferrini S J Immunol Res; 2015; 2015():696578. PubMed ID: 25961061 [TBL] [Abstract][Full Text] [Related]
16. [Effects of humanized interleukin 21 on anti-leukemic activity of cytokine induced killer cells and the mechanism]. Zhao N; Zhao MF; Rajbhandary S; Lu WY; Zhu HB; Xiao X; Deng Q; Li YM Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):823-8. PubMed ID: 23384903 [TBL] [Abstract][Full Text] [Related]
17. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells. Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400 [TBL] [Abstract][Full Text] [Related]
18. Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21. Ansén S; Butler MO; Berezovskaya A; Murray AP; Stevenson K; Nadler LM; Hirano N Clin Cancer Res; 2008 Oct; 14(19):6125-36. PubMed ID: 18829491 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 up-regulates interleukin-21R expression and interferon gamma production by CD8+ cells in SHIV-infected macaques. Zhao CC; Gao XQ; Xue J; Cong Z; Zhang WL; Chen T; Wu FX; Xiong J; Ju B; Su A; Wei Q; Qin C Exp Biol Med (Maywood); 2013 Apr; 238(4):400-9. PubMed ID: 23760006 [TBL] [Abstract][Full Text] [Related]
20. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]